The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future DevelopmentsJohn P. Veluchamy, Jan Spanholtz, Nina Kok et al.|Frontiers in Immunology|2017Cited by 197
Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal CancerJohn P. Veluchamy, Jan Spanholtz, Marleen Tordoir et al.|PLoS ONE|2016Cited by 85
In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal CancerJohn P. Veluchamy, Fenna Bohme, Nina Kok et al.|Frontiers in Immunology|2017Cited by 49
High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA statusJohn P. Veluchamy, Tanja D. de Gruijl, A. Marijne Heeren et al.|Cancer Immunology Immunotherapy|2016Cited by 35
Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and functionJohn P. Veluchamy, Jan Spanholtz, María Delso-Vallejo et al.|Scientific Reports|2017Cited by 30